John Bruce Williams, RPH, on behalf of North Okaloosa Medical Center filed on June 24, 2014.; The petitioner is seeking the Board’s interpretation as to whether the petitioner’s licensure as an acute care hospital with an Institutional Class 2 ...
RULE NO.:RULE TITLE:
64B16-28.602Institutional Class II Dispensing
NOTICE IS HEREBY GIVEN that the Board of Pharmacy has received the petition for declaratory statement from John Bruce Williams, RPH, on behalf of North Okaloosa Medical Center filed on June 24, 2014. The petition seeks the agency's opinion as to the applicability of Rule 64B16-28.602, F.A.C., as it applies to the petitioner.
The petitioner is seeking the Board’s interpretation as to whether the petitioner’s licensure as an acute care hospital with an Institutional Class 2 license and a Special Sterile Compounding Permit allows for post-surgical patients to be discharged to home while receiving an ongoing (2-3 day duration) infusion of non CS medication via elastomeric (single dose) pump device. Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.A copy of the Petition for Declaratory Statement may be obtained by contacting: Patrick Kennedy, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254 or by email at info@floridaspharmacy.gov.
Document Information
- Meeting:
- Rule 64B16-28.602, F.A.C.,
- Contact:
- Patrick Kennedy, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254or by email at info@floridaspharmacy.gov.
- Related Rules: (1)
- 64B16-28.602. Institutional Class II Dispensing